Preferred Dental Technologies Inc. (“Company”) (CSE: PDTI, US OTC: PDTTF): Announces results of Annual General and Special Meeting

PDTI Preferred Dental Technologies Inc. CSE:PDTI Technology, Medical Device, 牙科,科技,医疗设备
Published on: Jul 11, 2018

Preferred Dental Technologies Inc. (“Company”) (CSE: PDTI, US OTC: PDTTF) is pleased to announce results of its Annual General and Special Meeting of Shareholders (the “Meeting”) held on July 10, 2018 in Winnipeg, Manitoba.

The total number of shares represented by proxy at the time of voting cut off and by shareholders present in person at the meeting was 43,607,777 representing 68.54% of PDTI’s issued and outstanding Common Shares.

All matters put forward before shareholders for consideration and approval as set out in the Company’s Information Circular dated June 5, 2018, were approved by the requisite majority of votes cast at the Meeting.

The details of the voting results for the election of directors are set out below:

 

Nominee Votes cast FOR % of votes cast FOR Votes cast WITHHELD % of votes cast WITHHELD
George H. Gale 43,606,777 100.00 1,000 0.00
Erik Siegmund 42,617,555 97.73 990,222 2.27
Camille Pinette 42,617,555 97.73 990,222 2.27
John Schillinger 43,607,777 100.00 0 0.00
Lionel Gosselin 43,482,777 99.71 125,000 0.29

 

Shareholders also voted in favour of (i) re-appointment of Manning Elliott LLP as Auditors of the Corporation for the ensuing year and authorizing the Directors to fix their remuneration; (ii) to ratify and approve the continuation of the Stock Option Plan; (iii) to ratify the settlement of Debt Transaction 1; and (iv) to ratify the settlement of Debt Transaction 2.

About PDTI

Preferred Dental Technologies Inc. (PDTI) has been established to advance development and commercialization of various evolutionary and disruptive technologies in the dental implant industry.

MISSION – INNOVATIVE & PRACTICAL SOLUTIONS FOR THE DENTAL INDUSTRY

Visit: www.preferreddentalimplant.com www.prefdent.com

On behalf of Preferred Dental Technologies Inc.

Erik Siegmund

Chief Executive Officer Email: [email protected] Tel: 204.691.3722

www.prefdent.com

All product names referenced herein are trademarks of their respective companies.

This news release may contain forward-looking information which is not comprised of historical facts.

Forward-looking information involves risks, uncertainties and other factors that could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information. Forward-looking information in this news release may include, but is not limited to, the Company’s objectives, goals or future plans. Factors that could cause actual results to differ materially from such forward-looking information include, but are not limited to, those risks set out in the Company’s public documents filed on SEDAR. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law. Neither The Canadian Securities Exchange nor its Regulations Services Provider (as that term is defined in the policies of The Canadian Securities Exchange accepts responsibility for the adequacy or accuracy of this release.

Medical Device Technology